Aptus Pharma Ltd. · BSE:APPL
Aptus Pharma — Investor Presentation (February 2026)
35 slides from Aptus Pharma's investor presentation, Feb 7, 2026
Slide 1: Aptus Pharma Limited
© CORE VALUES © Quality e Trustworthiness Aptus Pharma Limited Connecting. sai. Life www.aptus-pharma.com | info@aptuspharma.com | export@aptuspharma.com | +91 76004 27827 07/02/2026 The Deputy Manager Corporate Relationship Department BSE Limited ; P. J. Towers, Dalal Street, Mumbai — 400001 Scrip
Slide 2: Investor Presentation
Aptus Pharma Connecting ....Life Investor Presentation
Slide 3: Safe Harbour Statement
Safe Harbour Statement This presentation contains forward-looking statements which may include statements relating to the Company’s expected financial performance, business prospects, growth strategy and future developments. Such forward-looking statements are based on current expectations, assumpti
Slide 4: At Aptus: Quality is a Habit
At Aptus: Quality is a Habit We Deliver Quality & Innovation To Redefine Human Lives Tejash Hathi (Managing Director) Aptus Pharma Limited... Connecting Life. Established in 2011, Aptus Pharma has been a stalwart in the pharmaceutical sales sector, contributing significantly to healthcare. Our commi
Slide 5: Company Overview
Company Overview 50 K+Prescription trusted 10 K + Every Day honourable Doctors 15+ therapeutic 17,721 sq. ft., Segments Central Warehouse Our Company is engaged in the business of marketing and distribution of finished pharmaceutical formulations. While the company does not own any manufacturing fac
Slide 6: Our Divisions
WellCare (Health And Personal Care Division) Vay (Cardiac Diabitic Division) Aptus Pharma Global (Pioneer Division) (Export Division)
Slide 7: Core Values
Core Values We commit to delivering the highest Quality Quality 01 Products and Services We Build Strong Relationships With stakeholders 02 Trustworthiness with foundations of intergrity and transparency Our Relentless pursuit of excellence drives Hardwork 03 trieless efforts and innovation 04 Commi
Slide 8: Brand Promise
“All Products Complies Standard Of cGMP & WHO” Brand Promise "We committed to healthcare and healthcare professionals." Aptus Pharma pledges to uphold the highest standards in contributing to the well-being of individuals and supporting the healthcare community.
Slide 9: Business Process
Business Process Aptus follows a structured and strategic business process to ensure efficient operations, quality assurance, and timely delivery of its pharmaceutical products. The end-to-end process, from demand estimation to distribution, is as follows: Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 D
Slide 10: Demand Estimation and Contract Manufacturer Selection
1. Demand Estimation of Product: The demand for each product is forecasted using a combination of historical sales and inventory data, along with predictive analysis based on market surveys. This helps in determining potential demand and planning inventory accordingly. Thereafter, the order quantity
Slide 11: Manufacturing, Quality Checks and Distribution
4. Manufacturing of Products: Based on the approved specifications and provided schedule, the contract manufacturer initiates the production process. The responsibility of sourcing raw materials rests with the contract manufacturer. To maintain transparency and product integrity, Manufacturers are r
Slide 12: Range of Solutions
Anti - Infectives Lipid-Lowering Antaacids & PPI Medicine G.I. Medicines Anti-Hypertensives & Anti -Allergic Cardiovascular Respiratory Medicine Medicine Range of Solutions Antidiabetic Medicine Nutritional Uro Care Supplements Wellness Product Anti-Inflammatory Ayush Products Pain Management Oct Pr
Slide 13: Leading Perception Brands
LW Leading Perception Brands us Chilkul-20 Rabapraznlo 20mg Chilkul-DSR Rabeprazale 20mg + les Domperidona S0reg {SR} = Bactiklin’ 200 FILM COATED Tablets Cefpadoxime 200mg Koltus-AB 200 Acobrophyline 200mg (SR) Tablets Chilkul-E40 Esomeprarele 40mg Tablets Chilkul-RAFT fact Sent conte Seaburn Algha
Slide 14: Brand Portfolio
‘Koltus-M Montelukast 10me + Levocetirizine Sng Tablets Patus-Total ‘Aptifresh-MD Mouth Dissolving Tablets Clonazepam 0.5mg ee | Telmisartan 40mg ‘stl * 7 pearpien imoee superene Nutritus.... Maftivitamin, Muttimineral, Brotin With __ Grape Seed Extract lio! Onéansttres 4mg ~ Jugsi-100 Sitagliptin 1
Slide 15: OTC & Wellness Products
ats OTC & Wellness Products
Slide 16: Quality Policy
Quality Policy At aptus "Quality is Habit." Our stringent quality measures encompass every stage, from raw material procurement to finished products. Employing cutting-edge methodologies such as HPLC, we meticulously conduct comprehensive batch-to-batch analysis. These rigorous tests encompass compo
Slide 17: Quality Parameters for each Batch
Impurity Compound Assay Complaince Dissolution And Distintegration Quality Hardness Test Profile Parameters for each U O C (Uniformity of Content) Batch Microbiology Study Related Substance Friability and Compliance Ph Level
Slide 18: Our Esteemed Manufacturers
Our Esteemed Manufacturers Our Loan License Manufacturing Facility Our Esteemed Contract Manufacturers of Our OTC Brands Our Esteemed Contract Manufacturing of Our Brands
Slide 19: Infrastructure Details
Infrastructure Details A Robust Contract Manufacturing Ecosystem Aptus Pharma works with multiple manufacturing partners, many of whom have been associated with the company for over many years. These long-standing relationships are built on consistent performance, transparent quality checks, and mut
Slide 20: Our Facilities
Our Facilities are hon © Ahmedabad
Slide 21: Ahmedabad Rajkot
Ahmedabad Rajkot
Slide 22: Proposed Corporate Office in Rajkot
Proposed Corporate Office in Rajkot 2205.31Sq.ft.
Slide 23: Announcements: OTC Expansion in Gujarat
Oo Aptus Pharma Limited frie tres tet Pa niente fecone shen erst pee sat ye te aed ee oe fea ape omer oe on fone fetes meat ivawdscery hae aie fee § we SS tee Se Reh ete Snaneome te ene tas eet Reteor st ruern graye re 4 19 Announcements Aptus Pharma Expands OTC Presence in Gujarat Ahmedabad, The le
Slide 24: Entry into the Urology Therapy Segment
Aptus Pharma announced its strategid entry into the Urology therapy segment Ahmedabad, The future revenue growth and Company will’ soon be profitability. The India Aptus Pharma Enters Fast- Pim ean Expanding : F , tl Its, It! Growing Urology Segment rramsulosin range, Alkalizer expanding at approxim
Slide 25: Events
Events Team Engagement Giving back to Activities Society Conference Investor Meet
Slide 26: Listing Ceremony
Aptus Pharma Limited Gs Fess Y WMeCtiNg. l
Slide 27: Mission Bharat
Mission Bharart West Zone - March 2027 Central Zone - March 2027 South Zone - March 2028 North & Northeast Zone - March 2029 Cosmeceuticals Plant March 2028
Slide 28: Awards & Certifications
Best Healthcare Brands - 2023 TQV CERTIFICATION OF COMPLIANCE Awards & Certifications WHO Certificate Best Company in Quality Control Indian 5000 MSME 2017 TQV CERTIFICATE
Slide 29: Key Milestones
Key Milestones 2011-16 2010 In 2011 Company Incorporation of our company formally launched with 2 headquarters and 11 under the name “Aptus Pharma products at a small scale, and grew by 2016 with Private Limited”. a product line of 50+ and approx. 25% of state-level presence. 2021-25 2016-20 The Com
Slide 30: Vision 2026-30
Vision 2026-30 03 Company will launch 450+ Products range and 25+ Therapeutic segments. 02 04 Company is eyeing horizontal Company introduced mission and vertical expansion in next 5 neighbour state i.e. Goa, years by making its strong Rajasthan, Madhya Pradesh, presence PAN India. Maharashtra and M
Slide 31: Our Management
Our Management Mr. Tejash Maheshchandra Hathi holds an MBA in Marketing and Management Accounting from Saurashtra University (2003) and is currently pursuing a PhD in Management from Rai University, Ahmedabad. He brings over two decades of rich experience in the pharmaceutical industry and has been
Slide 32: Mr. Ghanshyam Vinubhai Pansuriya
Mr Ghanshyam Vinubhai Pansuriya holds a Bachelor of Science degree (2007) from Saurashtra University and a Diploma in Pharmacy (2019) from Sunrise University. Mr Pansuriya joined the Company as a Director on August 12, 2010, and served in that capacity until April 29, 2024, onwards. He was subsequen
Slide 33: Mr. Riddhish Natwarlal Tanna and Mr. Nirav J. Pandya
Mr. Riddhish Natwarlal Tanna, aged 50 years, is the Non-Executive Director and one of the Promoters of the Company and also a homeopathic practitioner and healthcare management professional with experience in academic and administrative roles. He holds a Diploma in Homeopathic Medicine & Surgery (D.
Slide 34: Leadership Speak
Leadership Speak Contributing Towards People's Healthcare through providing high quality, reliable and sustainable pharmaceutical products. With this philosophy, We aim to contribute to health improvements with better treatment options by giving innovative & quality pharmaceuticals. Aptus Pharma is
Slide 35: Thank You
THANK YOU CS Mohini Gandhi +91 84602 06914 info@aptuspharma.com